Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Proceedings

Open Access

Comprehensive therapy for human H5N1

  • Jin Takasaki1Email author,
  • Shinyu Izumi1,
  • Nguyen Dang Tuan2,
  • Dao Xuan Co2,
  • Dang Hung Minh2,
  • Ngo Quy Chau2,
  • Nguyen Gia Binh2,
  • Vu Thi Van2,
  • Toshie Manabe1,
  • Pham Thi Phuong Thuy1, 2,
  • Tran Thuy Hanh2 and
  • Koichiro Kudo1
BMC Proceedings20115(Suppl 1):P10

https://doi.org/10.1186/1753-6561-5-S1-P10

Published: 10 January 2011

Introduction

The mortality of human H5N1 (pneumonia) is very high. The cumulative number of confirmed human cases of avian influenza A(H5N1) reported is 504, and 59.3% of them have been dead (situation on 12, August 2010). Early intervention could improve the prognosis of this disease.

Methods

In order to initiate appropriate treatment earlier, we perform a three step strategy named “Comprehensive Therapy for human A (H5N1): CT-H5N1” in northern Vietnam since 2008. Upon step 1, residents are educated to visit healthcare facilities sooner when he/she gets sick after close contact with sick/dead poultry; on Step 2, medical staffs in provincial hospitals make a diagnosis using a rapid diagnostic test for A(H5N1) that our colleagues developed. If positive, the patient is initiated antiviral treatments immediately and is referred to Central Hospital (BMH), if he/she is in severe condition; and on Step 3, the patient in critical condition is given advanced and intensive treatments including blood purification therapy.

Results

Since December, 2008, we have been able to enroll 3 patients into our collaborative clinical research. All of them successfully survive.

Conclusion

CT-H5N1 would be effective; however enrollment of more patients is desirable.

Authors’ Affiliations

(1)
Disease Control and Prevention Center (DCC)/ Department of Pulmonary Medicine, National Center for Global Health and Medicine (NCGM)
(2)
Back Mai Hospital

Copyright

© Takasaki et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement